Echographic tricky aspects in the athlete's heart

Size: px
Start display at page:

Download "Echographic tricky aspects in the athlete's heart"

Transcription

1 Paris 2016 ; January 13-16th 26 th European days of the French Society of Cardiology Sports and cardiology: an explosive cocktail? Echographic tricky aspects in the athlete's heart Eric Abergel Clinique Saint-Augustin, Bordeaux

2 Disclosure Statement of Financial Interest I currently have, or have had over the last two years, an affiliation or financial interests or interests of any order with a company or I receive compensation or fees or research grants with a commercial company : Affiliation/Financial Relationship Grant/Research Support Consulting Fees/Honoraria Major Stock Shareholder/Equity Royalty Income Ownership/Founder Intellectual Property Rights Other Financial Benefit Company none Daiichi Sankyo, MSD none none none none none

3 Cardiovascular causes of sudden death in young competitive athletes Maron BJ Circulation 2006;114:1633. USA Most common Hypertrophic CM (33%) Congenital coronary artery anomaly (14%) Less common Myocarditis Valvular heart disease (AS, Mitral prolapse) Atherosclerotic CAD Dilated CM ARVC Aortic rupture (Marfan) Corrado D JACC 2003;42:1959. Italian Most common ARVC (22%) Atherosclerotic CAD (18%) Congenital coronary artery anomaly (13%) Less common Myocarditis Mitral prolapse Premature CAD Dilated CM Hypertrophic CM (2%) Aortic rupture (Marfan)

4 Echocardiography in athletes: many potential pitfalls These diagnosis can be suspected in healthy athletes Overestimation of wall thickness (doctor!) Interpretation of LVH /other parameters HCM Interpretation of LVEF Interpretation of LV dilation Interpretation of a restrictive LV filling DCM Interpretation of RV dilation ARVC

5 Thickness: wrong measurement frequent, not innocent Referred for HCM, WT>> 15 mm Overestimation of septal thickness A current etiology of HCM in sport Tricuspid Subvalvular apparatus False chordae tendineae

6 Thickness: interpretation well codified HCM: Maximal WT 15 mm ; possible with WT mm Elliott PM. EHJ 2014;35: FEMALE (age 14-35) 720 M and F (age 14-18) 600 MALE (age 14-35) 3% (8 athletes) 0.4% (3 athletes) 6 3 Rawlins J. Circulation Sharma. JACC Basavarajaiah S. JACC Female Athlete 11 mm white 13 mm black Teenager (14-18 yold) 12 mm men 11 mm women Male Athlete 15 mm white 16 mm black...male adults athletes with maximal LVWT mm are in a grey zone Rare: around 2% of athletes, 5% of HCM Maron BJ. Circulation 2006;114:1633.

7 LVH : HCM or athlete s heart? Wrong measurement is not always a beginner s mistake Solution: don t focus only on wall thickness ; other parameters+++ Large LV cavity Very good LV relaxation Strongly support athlete s heart Question a WT>16 mm

8 LV cavity size: the most important discriminator between HCM and physiologic LVH 3500 elite athletes (75% male) LVIDd (mm)= 58.5±5.1 (45-65) Among 53 with LVH > 12 mm 50 had dilated LV cavity (>56 mm) Basavarajaiah S. JACC 2008;51: adolescents with HCM No LVD > 48 mm Maron BJ. JAMA 1999;281: HCM /28 elite athletes LVH Grey zone mm Cut-off LV diameter 54 mm Caselli S. Am J Cardiol 2014;114:1383.

9 LV cavity size: the most important discriminator 286 world class male cyclists (Tour de France) 25 cyclists with Maximal LVWT >13 mm 23 with LVIDd > 55 mm LVIDd (mm) 55 mm 13 mm MaxWT (mm) Abergel E. JACC 2004;44:144.

10 3D echo: Ratio LVmass/end diastolic volume 152 healthy volunteers ; 19 rowers ; 23 DCM ; 26 HCM 2.40±0.67 HCM 1.12±0.14 Athletes Volunteers 1.03±0.12 DCM 0.55±0.09 De Castro S. Heart 2007;93:205.

11 Mitral e (Pulsed DTI) e Author Number Subjects e infseptal cm/s e antlateral cm/s Caso Water Polo 13±3 16±4 Claessens Triathletes 16.3±1.7 Cardim Rower 13.3± ±3.4 Butz Hanball 13.2± ±3.4 D Andrea Endurance/power 14±3 16±5 Caselli All sports 13.8±2.2 ND Geske Sedentary HCM 5.3± ±2.3

12 E/A ratio and e 1145 Olympic athletes (61% men), 154 controls Caselli S. JASE 2015;28:236. E/A ratio (tip of the leaflets) e septal Athletes: E/A ratio always>1 Athletes: e septal always>8 cm/s Very suspicious All HCM have abnormal relaxation Abnormal relaxation: e sept< 8 cm/s Nagueh SF. JASE 2009 ;22:107.

13 Global LV longitudinal strain: a false friend? Football (n=28) mm Soccer (n=29) <13 mm Caselli S. J Am Soc Echocardiogr 2015;28:245 HCM (n=26) Controls (n=17) GLS% ± 4% ± 7.7% ± 2.0% * Bodybuilders AAS+(n=25) HCM (n=21) Bodybuilders AAS-(n=20) Controls (n=17) GLS% -17 ± 2% -15 ± 3% -18 ± 2% Kansal VM. AJC 2011;108:1322 Olympic Athletes (n=200) Controls (n=50) P value GLS% -18.1±2.2 (-15,-22) -19.4±2.3 (-16,-23) <.001 Richand V. AJC 2007;100: Controls (n=25) GLS% -15±5** -20±6-19±6 D Andrea A. Br J Sports Med 2007;13:149

14 HCM or Athlete's heart? Man > years old, wall thickness mm Athlete's heart LVIDd (> mm) E/A > 1 always e septal > 8 cm/s always» usually > cm/s Normal LV Longitudinal strain» caution: GLS may be low in athletes Normal mitral valve (morphology, position) No outflow obstruction (rest and exercise); possible after exercise HCM LVIDd < 48 mm E/A < 1 e < 8 cm/s Low LV Longitudinal strain Abnormal mitral valve (morphology, position)

15 What about athletes with HCM vs sedentary HCM athletes with HCM (14-35 years); 101 sedentary HCM - 15 Moderate HCM athletes vs 55 LVH healthy athletes LVEDD 51 mm (AUC 0.82) e 11 cm/s (AUC 0.88) In athletes with high suspicion for HCM, other non invasive cardiac tests are necessary Sheikh N. Circulation CVI 2015;8:xxx

16 MRI: the solution? Not always. Compare Echo and MRI in difficult cases

17 Physiological dilation or dilated cardiomyopathy? 1309 athletes, 38 sports (max impact: endurance cycling, swimming, Rowing, soccer) Majority with LVIDd<60 mm ; 14% with LVIDd>60 mm LVIDd: Men 55 mm (43-70 mm) LVIDd: Women 48 mm (38-66 mm) Follow up to 12 years without symptom Pelliccia. Ann Intern med 1999;130:23 Spirito AJC 1994;74:802 Restrictive mitral inflow is frequent Endurance Combined Strength Controls p Pluim BM Circulation 2000;101: studies ; 1451 athletes all sports

18 LVEF (%) LV Dilation : how to interpret? Dilation is usual, low LVEF is not rare 286 cyclists participating to the Tour de France (1995 et 1998) /286: LVIDd > 60 mm 17/286: LVID>60mm and LVEF<52% Abergel E. Am Heart J 1998;136:818 Abergel E. JACC 2004;44: LVIDd (mm) Suspicion of DCM in athletes: LV Dilation + Low LVEF+ DD Supporting athlete heart: High e ; LV contractile reserve Galderisi M EHJCVI 2015;16:353

19 Exercise echocardiography American football (static ++ endurance +) 156 athletes, 40% with LVEF between 50 and 55% (low normal) Exercise echo : appropriate hyperdynamic EF (76 ± 14%) Abernethy III JACC 2003;41: expert consensus of the European Association of Cardiovascular Imaging Galderisi M EHJCVI 2015;16:353 «Exercise stress echo in athletes with EF < 45 50% at rest to test if there is contractile reserve (=EF increase>70%) during exercise. Rest Exercise

20 RV dilation: normal adaptation or ARVC? Major ARVC criteria Regional RV akinesia, dyskinesia and RVOTp 32 mm (>19 mm/m 2 ) Marcus F. Circulation 2010;121: consecutive reasonable athletes competing at the regional, national, or international level Zaidi A. Circulation 2013;127:1783.

21 Adapted RV thresholds are required in athletes Parameter ASE nl 102 (86M) athletes 301 Male athletes 74 Female athletes RVOT Prox LA 33 mm 40 mm (20 mm/m 2 ) 37 mm (21 mm/m 2 ) RV basal diameter 42 mm < 38 mm/(m 2 ) mm (28 mm/m 2 ) Rudski LG. JASE 2010;23:685. Oxborough D. JASE 2012;25: mm (28 mm/m 2 ) Zaidi A. Circulation 2013;127:1783. Zaidi white 300 black Controls RVFAC 42±8% (44±8%) 42±9% (42±9%) S 15±3 cm/s (15±2) S 15±3 cm/s (15±1) La Gerche 2011/ endurance male Controls RVFAC 52±6% (52±8%) strain basal -22% (- 27%, p=0.018) Similar contractile reserve (exercise echo)

22 Normal adaptation or ARVC? Parameter Athletes ARVC RV dilation RV function RV Longitudinal strain Predominant RV basal enlargement No wall motion abnormality Normal or low Predominant RVOT enlargement Wall motion abnormality Low Exercise Echo Contractile reserve; nl strain No Contractile reserve LV dilation Yes No dilation RVOT proximal Long axis Dilation 40 mm man 37 mm woman 22 mm/m 2 both sex > 40 mm man > 37 mm woman

23 Large LVDD > mm E/A>1 E > cm/s Normal mitral valve No wall motion abnormality Predominant RV basal enlargment Strain nl/low ; Exercise nl HCM WT mm Avoid overestimation RVOT mm ARVC Athlete Heart Grey Zone DCM LVID mm ± Low LVEF at rest Exercise echo: Nl LVEF ± Restrictive mitral flow High E

24

25 Left atrium Volume index in highly trained athletes 615 athletes (370 endurance ; 245 strength-trained) D Andrea A. Am H J 2010;159:1155

26 Other physiological modifications Proportional dilation of both ventricles Echo and MRI study Scharhag J. JACC 2002;40:1856. Inferior vena cava dilation 58 high level athletes, swimmers++» 23 ± 5 mm vs 11 ± 1 mm (30 controls) Goldhammer E. JASE 1999;12:988. Aortic root dilatation very uncommon 0,26% chez 1929 athletes years old (basketball) Frequent MR Kinoshita N. AmHJ 2000;139:723. Douglas PS. AJC 1989 ; 64 : 209.

27 Echocardiographic pitfalls in the diagnosis of HCM Prasad K. Heart 1999;82 (supp III):III8.

28 Take into account load to interpret FS/LVEF Endurance or combined: Low LVEF at rest is not rare Low preload at rest LVEF (Simpson)= 53% LVd = 58 mm LVs = 42 mm FS = 28% LVEF Lifters Runners Controls End-systolic wall stress Professional soccer player Paris Saint Germain season 2001 Colan SD. JACC 1987;9:776.

29 How can we explain asymmetric RV remodeling? Important increase in pulmonary artery pressure in athletes during exercise REST PEAK EXERCISE Author/ TR gdt controls TR gdt athletes TR gdt controls TR gdt athletes Bossone hockey players 12 mmhg (9-15) 21 mmhg (18-23) 21 mmhg (15-27) 47 mmhg (38-55) La Gerche endurance male 22 ± 4 mmhg 22±4 mmhg 47±7 mmhg 61±13 mmhg Pressure excess counterbalanced by reduction in cavity and/or increase in wall thickness? (T=P r/h) La Gerche A. Med Sci Sports Exerc 2011;43:974

30 Echo: similar RV and LV remodeling in endurance athletes? 127 endurance athletes: cardiac enlargement occurs symmetrically in both right and left cavities Henriksen. Eur Heart J 1996;25:263. RV LV 102 endurance athletes Asymetric enlargement. Normality threshold for RV/LV ratio < 1.17 Oxborough D. JASE 2012;25:263.

31 How can we explain asymmetric RV remodeling 39 endurance athletes, 14 non athletes MRI (Ventricular size r and thickness h ), Exercise echo (SPAP) ESS (SPAP x r/2h) LV RV Exercise induces a relative increase in RVES-stress which exceeds LVES-stress. In athletes, greater RV enlargement and greater wall thickening may be a product of this disproportionate load excess. La Gerche A. Med Sci Sports Exerc 2011;43:974

Hypertrophic Cardiomyopathy or «Athlete s Heart»

Hypertrophic Cardiomyopathy or «Athlete s Heart» Hypertrophic Cardiomyopathy or «Athlete s Heart» S. GUERARD, J-R. CAIGNAULT, V. GRIFFET Desgenettes Military Hospital LYON Déclaration de Relations Professionnelles Disclosure Statement of Financial Interest

More information

Echocardiography of the young athlete: Where are the limits? 24 èmes Journées Européennes de la Société Française de cardiologie janvier 2014

Echocardiography of the young athlete: Where are the limits? 24 èmes Journées Européennes de la Société Française de cardiologie janvier 2014 Echocardiography of the young athlete: Where are the limits? 24 èmes Journées Européennes de la Société Française de cardiologie 15-18 janvier 2014 Sylvain GUERARD LYON-BRON Déclaration de Relations Professionnelles

More information

The Athlete s Heart. Critical Role of Echo. Neil J. Weissman, MD MedStar Health Research Institute & Professor of Medicine Georgetown University

The Athlete s Heart. Critical Role of Echo. Neil J. Weissman, MD MedStar Health Research Institute & Professor of Medicine Georgetown University The Athlete s Heart Critical Role of Echo Neil J. Weissman, MD MedStar Health Research Institute & Professor of Medicine Georgetown University Washington, D.C. Disclosures Grant support (to institution)

More information

Cardiac hypertrophy : differentiating disease from athlete

Cardiac hypertrophy : differentiating disease from athlete Cardiac hypertrophy : differentiating disease from athlete Ario Soeryo Kuncoro, MD, Cardiologist Echocardiography Division, National Cardiovascular Centre Harapan Kita-Jakarta Departement of Cardiology

More information

The Athlete s Heart. Role of Echo. Neil J. Weissman, MD MedStar Health Research Institute & Professor of Medicine Georgetown University

The Athlete s Heart. Role of Echo. Neil J. Weissman, MD MedStar Health Research Institute & Professor of Medicine Georgetown University The Athlete s Heart Role of Echo Neil J. Weissman, MD MedStar Health Research Institute & Professor of Medicine Georgetown University Washington, D.C. Disclosures Grant support (to institution) for Core

More information

Nancy Goldman Cutler, MD Beaumont Children s Hospital Royal Oak, Mi

Nancy Goldman Cutler, MD Beaumont Children s Hospital Royal Oak, Mi Nancy Goldman Cutler, MD Beaumont Children s Hospital Royal Oak, Mi Identify increased LV wall thickness (WT) Understand increased WT in athletes Understand hypertrophic cardiomyopathy (HCM) Enhance understanding

More information

Right ventricular adaptation in endurance athletes. António Freitas. No conflict of interest

Right ventricular adaptation in endurance athletes. António Freitas. No conflict of interest The role of echocardiography in sports cardiology Right ventricular adaptation in endurance athletes. António Freitas Cardiology Department - Fernando Fonseca Hospital Lisbon Sports Medicine Centre - Lisbon

More information

Prevalence of Modified ARVC Task Force Criteria in Elite Male Athletes

Prevalence of Modified ARVC Task Force Criteria in Elite Male Athletes ESC Congress Paris 2011 Prevalence of Modified ARVC Task Force Criteria in Elite Male Athletes A Zaidi, N Sheikh, S Gati, S Ghani, R Howes, S Sharma St George s, University of London, United Kingdom Conflict

More information

Athlete s Heart vs. Cardiomyopathy

Athlete s Heart vs. Cardiomyopathy Athlete s Heart vs. Cardiomyopathy Linda D. Gillam, MD, MPH, FASE Chair, Department of Cardiovascular Medicine Medical Director, Cardiovascular Service Line Former Team Cardiologist to the New York Jets

More information

Echo Evaluation of the Heart of an Athlete

Echo Evaluation of the Heart of an Athlete Echo Evaluation of the Heart of an Athlete 18 th SA Heart Congress, 2017 Johannesburg, South Africa November 9-12, 2017 Naser Ammash. MD Professor of Medicine Practice Chair, Cardiovascular Department

More information

Novel echocardiographic modalities: 3D echo, speckle tracking and strain rate imaging. Potential roles in sports cardiology. Stefano Caselli, MD, PhD

Novel echocardiographic modalities: 3D echo, speckle tracking and strain rate imaging. Potential roles in sports cardiology. Stefano Caselli, MD, PhD Novel echocardiographic modalities: 3D echo, speckle tracking and strain rate imaging. Potential roles in sports cardiology. Stefano Caselli, MD, PhD Ospedale San Pietro Fatebenefratelli Rome, Italy Differential

More information

The Athletic Heart Takes Shape: Overview of Cardiac Remodeling Rory B. Weiner, MD

The Athletic Heart Takes Shape: Overview of Cardiac Remodeling Rory B. Weiner, MD The Athletic Heart Takes Shape: Overview of Cardiac Remodeling Rory B. Weiner, MD Cardiovascular Performance Program, MGH Assistant Professor of Medicine, Harvard Medical School Outline Athlete s Heart

More information

Athlete s Heart vs. Cardiomyopathy

Athlete s Heart vs. Cardiomyopathy Athlete s Heart vs. Cardiomyopathy Linda D. Gillam, MD, MPH, FASE Chair, Department of Cardiovascular Medicine Medical Director, Cardiovascular Service Line Former Team Cardiologist to the New York Jets

More information

Athlete s Heart: Clinical Relevance. Athlete's Heart vs. Cardiac Pathology Clinical Approaches. Echo Florida Conflicts of Interest: None

Athlete s Heart: Clinical Relevance. Athlete's Heart vs. Cardiac Pathology Clinical Approaches. Echo Florida Conflicts of Interest: None Athlete's Heart vs. Cardiac Pathology Clinical Approaches Echo Florida 2012 Aaron L. Baggish MD Cardiovascular Performance Program Cardiac Ultrasound Laboratory Division of Cardiology Massachusetts General

More information

Historical Notes: Clinical Exercise Testing in the Athlete. An Efficient Heart. Structural Changes, Cont. Coronary Arteries

Historical Notes: Clinical Exercise Testing in the Athlete. An Efficient Heart. Structural Changes, Cont. Coronary Arteries Clinical Exercise Testing in the Athlete The athlete s heart Sudden cardiac death in athletes Screening athletes for cardiovascular disease Historical Notes: Giovanni Lancisi (father of cardiology), 17

More information

Screening of Children and Adolescents at Risk of Sudden Cardiac Arrest: What Is the Utility of Non-Invasive Imaging?

Screening of Children and Adolescents at Risk of Sudden Cardiac Arrest: What Is the Utility of Non-Invasive Imaging? Screening of Children and Adolescents at Risk of Sudden Cardiac Arrest: What Is the Utility of Non-Invasive Imaging? Beth F. Printz, M.D., Ph.D. Medical Director, Non-Invasive Imaging Rady Children s Hospital,

More information

EVALUATION OF THE ATHLETE. Karen Stout, MD Professor, Medicine and Pediatrics University of Washington

EVALUATION OF THE ATHLETE. Karen Stout, MD Professor, Medicine and Pediatrics University of Washington EVALUATION OF THE 12 ATHLETE Karen Stout, MD Professor, Medicine and Pediatrics University of Washington NO DISCLOSURES OUTLINE Why evaluate athletes? What s the problem? What evaluation should be done?

More information

Athletes with cardiac disease; dead and buried or chance for resurrection?

Athletes with cardiac disease; dead and buried or chance for resurrection? Athletes with cardiac disease; dead and buried or chance for resurrection? EuroPRevent 2011 Geneva F. Carré University Rennes 1-Pontchaillou Hospital Inserm U642, Rennes - F-35000 Risk of physical activity

More information

Key wards: PR Interval, QT interval, bradycardia.

Key wards: PR Interval, QT interval, bradycardia. bü z ÇtÄ TÜà väx : A Pilot Study Eman Abdo Elaziz Ahmed 1 and Amal Mahmoud Saied 2 Abstract Background: Sudden deaths of young competitive athletes are tragic events that continue to have a considerable

More information

Sudden Death in Athletes: What is the role of ECG Screening?

Sudden Death in Athletes: What is the role of ECG Screening? Sudden Death in Athletes: What is the role of ECG Screening? Byron K. Lee MD Professor of Medicine Director of EP Laboratory leeb@medicine.ucsf.edu Division of Cardiology Cardiac Electrophysiology Arrhythmias,

More information

Sudden Cardiac Death in Sports: Causes and Current Screening Recommendations

Sudden Cardiac Death in Sports: Causes and Current Screening Recommendations Sports Cardiology Sudden Cardiac Death in Sports: Causes and Current Screening Recommendations Domenico Corrado, MD, PhD Inherited Arrhytmogenic Cardiomyopathy Unit Department of Cardiac, Thoracic and

More information

Professor Sanjay Sharma St George s University of London

Professor Sanjay Sharma St George s University of London How to Evaluate an Athlete of Afro- Caribbean Origin. Professor Sanjay Sharma St George s University of London Background: Causes of SCD in Sport Young competitive athlete Personal and family history Physical

More information

27-year-old professionnal rugby player: asymptomatic

27-year-old professionnal rugby player: asymptomatic 27-year-old professionnal rugby player: asymptomatic Benefits and limits of cardiac MRI in the young athlete with a suspected heart disease. Philippe PAULE Service de Cardiologie, HIA Clermont Tonnerre,

More information

NEW GUIDELINES MAJOR ECHOCARDIOGRAPHIC CRITERIA FOR ARVC MINOR ECHOCARDIOGRAPHIC CRITERIA FOR ARVC

NEW GUIDELINES MAJOR ECHOCARDIOGRAPHIC CRITERIA FOR ARVC MINOR ECHOCARDIOGRAPHIC CRITERIA FOR ARVC NEW GUIDELINES The Echocardiographic Assessment of the Right Ventricle with particular reference to Arrhythmogenic Right Ventricular Cardiomyopathy A Protocol of the British Society of Echocardiography

More information

Cardiac hypertrophy and how it may break an athlete s heart e the Cypriot case

Cardiac hypertrophy and how it may break an athlete s heart e the Cypriot case Eur J Echocardiography (2005) 6, 301e307 Cardiac hypertrophy and how it may break an athlete s heart e the Cypriot case C.E. Chee a,1, C.P. Anastassiades a,1, A.G. Antonopoulos b, A.A. Petsas b, L.C. Anastassiades

More information

R egular intensive physical exercise is associated with an

R egular intensive physical exercise is associated with an 495 CARDIOVASCULAR MEDICINE Physiological upper limits of ventricular cavity size in highly trained adolescent athletes J Makan, S Sharma, S Firoozi, G Whyte, P G Jackson, W J McKenna... See end of article

More information

Value of echocardiography in chronic dyspnea

Value of echocardiography in chronic dyspnea Value of echocardiography in chronic dyspnea Jahrestagung Schweizerische Gesellschaft für /Schweizerische Gesellschaft für Pneumologie B. Kaufmann 16.06.2016 Chronic dyspnea Shortness of breath lasting

More information

Introduction. Abbreviations and Definitions

Introduction. Abbreviations and Definitions Abbreviations and Definitions HCM DCM LVH ARVC LAD LV LA RV RA IVSd LVPWd LVDd EDV SV EF LA Size LVNC LBBB RBBB RWT Hypertrophic Cardiomyopathy Dilated Cardiomyopathy Left Ventricular Hypertrophy Arrhythmogenic

More information

RIGHT VENTRICULAR SIZE AND FUNCTION

RIGHT VENTRICULAR SIZE AND FUNCTION RIGHT VENTRICULAR SIZE AND FUNCTION Edwin S. Tucay, MD, FPCC, FPCC, FPSE Philippine Society of Echocardiography Quezon City, Philippines Echo Mission, BRTTH, Legaspi City, July 1-2, 2016 NO DISCLOSURE

More information

Restrictive Cardiomyopathy

Restrictive Cardiomyopathy ESC Congress 2011, Paris Imaging Unusual Causes of Cardiomyopathy Restrictive Cardiomyopathy Kazuaki Tanabe, MD, PhD Professor of Medicine Chair, Division of Cardiology Izumo, Japan I Have No Disclosures

More information

CLINICAL RESEARCH ON CARDIOVASCULAR ALTERATION ON 86 S PROFESSIONAL ATHLETES IN IRAN

CLINICAL RESEARCH ON CARDIOVASCULAR ALTERATION ON 86 S PROFESSIONAL ATHLETES IN IRAN CLINICAL RESEARCH ON CARDIOVASCULAR ALTERATION ON 86 S PROFESSIONAL ATHLETES IN IRAN Lotfali Pourkazemi 1 * and Roghieh Razeghi Jadid 2 1 Sports Medicine Federation of Iran 2 Department of Herbal Sciences,

More information

LV FUNCTION ASSESSMENT: WHAT IS BEYOND EJECTION FRACTION

LV FUNCTION ASSESSMENT: WHAT IS BEYOND EJECTION FRACTION LV FUNCTION ASSESSMENT: WHAT IS BEYOND EJECTION FRACTION Jamilah S AlRahimi Assistant Professor, KSU-HS Consultant Noninvasive Cardiology KFCC, MNGHA-WR Introduction LV function assessment in Heart Failure:

More information

CARDIAC BENEFICIAL EFFECTS AND ADAPTATIONS IN ATHLETES

CARDIAC BENEFICIAL EFFECTS AND ADAPTATIONS IN ATHLETES ARISTOTLE UNIVERSITY OF THESSALONIKI, GREECE SPORTS MEDICINE LABORATORY DIRECTOR: PROF. A. DELIGIANNIS CARDIAC BENEFICIAL EFFECTS AND ADAPTATIONS IN ATHLETES ASTERIOS DELIGIANNIS CARDIOLOGIST PROFESSOR

More information

Managing Hypertrophic Cardiomyopathy with Imaging. Gisela C. Mueller University of Michigan Department of Radiology

Managing Hypertrophic Cardiomyopathy with Imaging. Gisela C. Mueller University of Michigan Department of Radiology Managing Hypertrophic Cardiomyopathy with Imaging Gisela C. Mueller University of Michigan Department of Radiology Disclosures Gadolinium contrast material for cardiac MRI Acronyms Afib CAD Atrial fibrillation

More information

SABIHA GATI AND SANJAY SHARMA

SABIHA GATI AND SANJAY SHARMA 9 The athlete s heart SABIHA GATI AND SANJAY SHARMA Pasieka/Science Photo Library In this article, the authors highlight the spectrum, magnitude and determinants of the athlete s heart and provide a practical

More information

Risk Factors for Sudden cardiac Death

Risk Factors for Sudden cardiac Death Risk Factors for Sudden cardiac Death A. Arenal Arrhythmias in competitive sports Disclosure Conflict of interest Advisory board: Medtronic, Boston Scientific Research grants: Medtronic, Boston Scientific,

More information

I have nothing to disclose. Research support from: Cardiac Risk in The Young

I have nothing to disclose. Research support from: Cardiac Risk in The Young I have nothing to disclose. Research support from: Cardiac Risk in The Young Pre-participation screening of Young Athletes: Current Perspective Professor Sanjay Sharma Disclosures: None SCD in Young Athletes

More information

Cardiac Conditions in Sport & Exercise. Cardiac Conditions in Sport. USA - Sudden Cardiac Death (SCD) Dr Anita Green. Sudden Cardiac Death

Cardiac Conditions in Sport & Exercise. Cardiac Conditions in Sport. USA - Sudden Cardiac Death (SCD) Dr Anita Green. Sudden Cardiac Death Cardiac Conditions in Sport & Exercise Dr Anita Green Cardiac Conditions in Sport Sudden Cardiac Death USA - Sudden Cardiac Death (SCD)

More information

Echocardiographic Evaluation of the Cardiomyopathies. Stephanie Coulter, MD, FACC, FASE April, 2016

Echocardiographic Evaluation of the Cardiomyopathies. Stephanie Coulter, MD, FACC, FASE April, 2016 Echocardiographic Evaluation of the Cardiomyopathies Stephanie Coulter, MD, FACC, FASE April, 2016 Cardiomyopathies (CMP) primary disease intrinsic to cardiac muscle Dilated CMP Hypertrophic CMP Infiltrative

More information

Echocardiographie de la Tétralogie de Fallot opérée

Echocardiographie de la Tétralogie de Fallot opérée Echocardiographie de la Tétralogie de Fallot opérée Diala Khraiche M3C-Necker Enfants malades, Université Paris Descartes Paris, France. Disclosure Statement of Financial Interest I currently have, or

More information

Jonathan Kim MD, FACC

Jonathan Kim MD, FACC Jonathan Kim MD, FACC Assistant Professor, Division of Cardiology, Emory University Adjunct Assistant Professor, School of Applied Physiology, Georgia Tech Team Cardiologist, Sports Medicine, Emory University

More information

Evalua&on)of)Le-)Ventricular)Diastolic) Dysfunc&on)by)Echocardiography:) Role)of)Ejec&on)Frac&on)

Evalua&on)of)Le-)Ventricular)Diastolic) Dysfunc&on)by)Echocardiography:) Role)of)Ejec&on)Frac&on) Evalua&on)of)Le-)Ventricular)Diastolic) Dysfunc&on)by)Echocardiography:) Role)of)Ejec&on)Frac&on) N.Koutsogiannis) Department)of)Cardiology) University)Hospital)of)Patras)! I have no conflicts of interest

More information

Ιπποκράτειες μέρες καρδιολογίας Θεσσαλονίκη, 9-10 Μαρτίου Φωτεινή Α. Λαζαρίδου Επιμελήτρια Α Γενικό Νοσοκομείο Αγιος Παύλος, Θεσσαλονίκη

Ιπποκράτειες μέρες καρδιολογίας Θεσσαλονίκη, 9-10 Μαρτίου Φωτεινή Α. Λαζαρίδου Επιμελήτρια Α Γενικό Νοσοκομείο Αγιος Παύλος, Θεσσαλονίκη Ιπποκράτειες μέρες καρδιολογίας Θεσσαλονίκη, 9-10 Μαρτίου 2018 Φωτεινή Α. Λαζαρίδου Επιμελήτρια Α Γενικό Νοσοκομείο Αγιος Παύλος, Θεσσαλονίκη RV shape Triangular shape in frontal plane crescent shape in

More information

Quantitation of right ventricular dimensions and function

Quantitation of right ventricular dimensions and function SCCS Basics of cardiac assessment Quantitation of right ventricular dimensions and function Tomasz Kukulski, MD PhD Dept of Cardiology, Congenital Heart Disease and Electrotherapy Silesian Medical University

More information

Diastolic filling in hypertrophied hearts of elite runners: an Echo-Doppler study

Diastolic filling in hypertrophied hearts of elite runners: an Echo-Doppler study European Review for Medical and Pharmacological Sciences 2001; 5: 65-69 Diastolic filling in hypertrophied hearts of elite runners: an Echo-Doppler study A. PALAZZUOLI, L. PUCCETTI, F. BRUNI, A.L. PASQUI,

More information

Utility of Echocardiography

Utility of Echocardiography Hypertrophic Cardiomyopathy and Beyond- Echo Hawaii 2018 Lawrence Rudski MD FRCPC FACC FASE Professor of Medicine Director, Division of Cardiology and Azrieli Heart Center Jewish General Hospital, McGill

More information

Pulmonary Hypertension. Echocardiography: Pearls & Pitfalls

Pulmonary Hypertension. Echocardiography: Pearls & Pitfalls Pulmonary Hypertension Echocardiography: Pearls & Pitfalls Αθανάσιος Γ. Κουτσάκης Ειδικευόμενος Καρδιολογίας Α Καρδιολογική Κλινική ΑΠΘ Σεμινάρια Ομάδων Εργασίας Ελληνικής Καρδιολογικής Εταιρείας Ιωάννινα,

More information

Echocardiography. Guidelines for Valve and Chamber Quantification. In partnership with

Echocardiography. Guidelines for Valve and Chamber Quantification. In partnership with Echocardiography Guidelines for Valve and Chamber Quantification In partnership with Explanatory note & references These guidelines have been developed by the Education Committee of the British Society

More information

Diastolic Function Assessment New Guideline Update Practical Approach

Diastolic Function Assessment New Guideline Update Practical Approach Mayo Clinic Department of Cardiovascular Diseases Mayo Clinic Echocardiography Review Course for Boards and Recertification Diastolic Function Assessment New Guideline Update Practical Approach Jae K.

More information

Imaging Assessment of Aortic Stenosis/Aortic Regurgitation

Imaging Assessment of Aortic Stenosis/Aortic Regurgitation Imaging Assessment of Aortic Stenosis/Aortic Regurgitation Craig E Fleishman, MD FACC FASE The Heart Center at Arnold Palmer Hospital for Children, Orlando SCAI Fall Fellows Course 2014 Las Vegas Disclosure

More information

EVALUATION OF ELECTROCARDIOGRAPHIC FINDINGS IN ATHLETES

EVALUATION OF ELECTROCARDIOGRAPHIC FINDINGS IN ATHLETES EVALUATION OF ELECTROCARDIOGRAPHIC FINDINGS IN ATHLETES UNIT OF INHERITED CV DISEASES HEART CENTER OF THE YOUNG AND ATHLETES A DPT OF CARDIOLOGY UNIVERSITY OF ATHENS EVALUATION OF ELECTROCARDIOGRAPHIC

More information

Mædica - a Journal of Clinical Medicine ORIGIN. How to differentiate athlete s heart from pathological cardiac hypertrophy?

Mædica - a Journal of Clinical Medicine ORIGIN. How to differentiate athlete s heart from pathological cardiac hypertrophy? Mædica - a Journal of Clinical Medicine ORIGIN RIGINAL PAPERS APERS: CLINICAL OR BASIC RESEARCH How to differentiate athlete s heart from pathological cardiac hypertrophy? Maria FLORESCU, MD, Dragos VINEREANU,

More information

Rest and Exercise Echocardiography in Hypertrophic Cardiomyopathy: Determinants of Exercise Peak Gradient and Predictors of Outcome

Rest and Exercise Echocardiography in Hypertrophic Cardiomyopathy: Determinants of Exercise Peak Gradient and Predictors of Outcome Rest and Exercise Echocardiography in Hypertrophic Cardiomyopathy: Determinants of Exercise Peak Gradient and Predictors of Outcome G. Deswarte, AS. Polge, N. Lamblin, A. Millaire, M. Richardson, C. Bauters,

More information

HEART CONDITIONS IN SPORT

HEART CONDITIONS IN SPORT HEART CONDITIONS IN SPORT Dr. Anita Green CHD Risk Factors Smoking Hyperlipidaemia Hypertension Obesity Physical Inactivity Diabetes Risks are cumulative (multiplicative) Lifestyles predispose to RF One

More information

Imaging in dilated cardiomyopathy : factors associated with a poor outcome

Imaging in dilated cardiomyopathy : factors associated with a poor outcome Imaging in dilated cardiomyopathy : factors associated with a poor outcome Johan De Sutter, MD, PhD, FESC AZ Maria Middelares Gent and University Gent - Belgium Dilated cardiomyopathy Cardiomyopathy with

More information

Degenerative Mitral Regurgitation: Etiology and Natural History of Disease and Triggers for Intervention

Degenerative Mitral Regurgitation: Etiology and Natural History of Disease and Triggers for Intervention Degenerative Mitral Regurgitation: Etiology and Natural History of Disease and Triggers for Intervention John N. Hamaty D.O. FACC, FACOI November 17 th 2017 I have no financial disclosures Primary Mitral

More information

Appendix II: ECHOCARDIOGRAPHY ANALYSIS

Appendix II: ECHOCARDIOGRAPHY ANALYSIS Appendix II: ECHOCARDIOGRAPHY ANALYSIS Two-Dimensional (2D) imaging was performed using the Vivid 7 Advantage cardiovascular ultrasound system (GE Medical Systems, Milwaukee) with a frame rate of 400 frames

More information

Diastolic Heart Function: Applying the New Guidelines Case Studies

Diastolic Heart Function: Applying the New Guidelines Case Studies Diastolic Heart Function: Applying the New Guidelines Case Studies Mitral Regurgitation The New ASE William Guidelines: A. Zoghbi Role MD, of FASE, 2D/3D MACCand CMR Professor and Chairman, Department

More information

Chamber Quantitation Guidelines: What is New?

Chamber Quantitation Guidelines: What is New? Chamber Quantitation Guidelines: What is New? Roberto M Lang, MD J AM Soc Echocardiogr 2005; 18:1440-1463 1 Approximately 10,000 citations iase in itune Cardiac Chamber Quantification: What is New? Database

More information

Imaging in Heart Failure: A Multimodality Approach. Thomas Ryan, MD

Imaging in Heart Failure: A Multimodality Approach. Thomas Ryan, MD Imaging in Heart Failure: A Multimodality Approach Thomas Ryan, MD Heart Failure HFrEF HFpEF EF50% Lifetime risk 20% Prevalence 6M Americans Societal costs - $30B 50% 5-year survival 1 Systolic

More information

Quantification of Cardiac Chamber Size

Quantification of Cardiac Chamber Size 2017 KSE 2017-11-25 Quantification of Cardiac Chamber Size Division of Cardiology Keimyung University Dongsan Medical Center In-Cheol Kim M.D., Ph.D. LV size and function Internal linear dimensions PLX

More information

La valutazione dell atleta: è una strategia salva-vita e costo-efficace?

La valutazione dell atleta: è una strategia salva-vita e costo-efficace? La valutazione dell atleta: è una strategia salva-vita e costo-efficace? Primo trattato di Medicina Wilson and Jungner s criteria In the 1960s the World Health Organization adopted the Wilson and Jungner

More information

How NOT to miss Hypertrophic Cardiomyopathy? Adaya Weissler-Snir, MD University Health Network, University of Toronto

How NOT to miss Hypertrophic Cardiomyopathy? Adaya Weissler-Snir, MD University Health Network, University of Toronto How NOT to miss Hypertrophic Cardiomyopathy? Adaya Weissler-Snir, MD University Health Network, University of Toronto Introduction Hypertrophic cardiomyopathy is the most common genetic cardiomyopathy,

More information

L essentiel de 2013 Exercice Readaptation et Sport (GERS) Dr Marie Christine Iliou

L essentiel de 2013 Exercice Readaptation et Sport (GERS) Dr Marie Christine Iliou PARIS 15-19 Janvier 2014 L essentiel de 2013 Exercice Readaptation et Sport (GERS) Dr Marie Christine Iliou Déclaration de Relations Professionnelles Disclosure Statement of Financial Interest J'ai actuellement,

More information

Sports Cardiology Highlights from EuroPRevent 2012 Dublin

Sports Cardiology Highlights from EuroPRevent 2012 Dublin Sports Cardiology Highlights from EuroPRevent 2012 Dublin Hein Heidbuchel Cardiology Arrhythmology, University of Leuven, Belgium Past Chair, A Registered Branch of the ESC Sports Cardiology Highlights

More information

LA Function analysis Marcia Barbosa Vice Presidente - Brazilian Soc of Cardiology President-elect - Interamerican Soc of Cardiology

LA Function analysis Marcia Barbosa Vice Presidente - Brazilian Soc of Cardiology President-elect - Interamerican Soc of Cardiology LA Function analysis Marcia Barbosa Vice Presidente - Brazilian Soc of Cardiology President-elect - Interamerican Soc of Cardiology Belo Horizonte Brazil DECLARATION OF CONFLICT OF INTEREST Nothing to

More information

Anaesthesia for non-cardiac surgery in patients left ventricular outflow tract obstruction (LVOTO)

Anaesthesia for non-cardiac surgery in patients left ventricular outflow tract obstruction (LVOTO) Anaesthesia for non-cardiac surgery in patients left ventricular outflow tract obstruction (LVOTO) Dr. Siân Jaggar Consultant Anaesthetist Royal Brompton Hospital London UK Congenital Cardiac Services

More information

HYPERTROPHY: Behind the curtain. V. Yotova St. Radboud Medical University Center, Nijmegen

HYPERTROPHY: Behind the curtain. V. Yotova St. Radboud Medical University Center, Nijmegen HYPERTROPHY: Behind the curtain V. Yotova St. Radboud Medical University Center, Nijmegen Disclosure of interest: none Relative wall thickness (cm) M 0.22 0.42 0.43 0.47 0.48 0.52 0.53 F 0.24 0.42 0.43

More information

Echocardiographic Cardiovascular Risk Stratification: Beyond Ejection Fraction

Echocardiographic Cardiovascular Risk Stratification: Beyond Ejection Fraction Echocardiographic Cardiovascular Risk Stratification: Beyond Ejection Fraction October 4, 2014 James S. Lee, M.D., F.A.C.C. Associates in Cardiology, P.A. Silver Spring, M.D. Disclosures Financial none

More information

Echo Assessment Pre-TAVI

Echo Assessment Pre-TAVI Disclosure Statement of Financial Interest Within the past 12 months, I or my spouse/partner have had a financial Interest /arrangement or affiliation with the organization(s) listed below Echocardiographic

More information

LV geometric and functional changes in VHD: How to assess? Mi-Seung Shin M.D., Ph.D. Gachon University Gil Hospital

LV geometric and functional changes in VHD: How to assess? Mi-Seung Shin M.D., Ph.D. Gachon University Gil Hospital LV geometric and functional changes in VHD: How to assess? Mi-Seung Shin M.D., Ph.D. Gachon University Gil Hospital LV inflow across MV LV LV outflow across AV LV LV geometric changes Pressure overload

More information

Mitral valve apparatus in Hypertrophic Cardiomyopathy: a specific assessment?

Mitral valve apparatus in Hypertrophic Cardiomyopathy: a specific assessment? Nancy, September 17th, 2015 Mitral valve apparatus in Hypertrophic Cardiomyopathy: a specific assessment? Inserm UMR1087 Institut du Thorax, Nantes Thierry le Tourneau Déclaration de Relations Professionnelles

More information

Highlights from EuroEcho 2009 Echo in cardiomyopathies

Highlights from EuroEcho 2009 Echo in cardiomyopathies Highlights from EuroEcho 2009 Echo in cardiomyopathies Bogdan A. Popescu University of Medicine and Pharmacy, Bucharest, Romania ESC Congress 2010 Hypertrophic cardiomyopathy To determine the differences

More information

Evaluation of Left Ventricular Diastolic Dysfunction by Doppler and 2D Speckle-tracking Imaging in Patients with Primary Pulmonary Hypertension

Evaluation of Left Ventricular Diastolic Dysfunction by Doppler and 2D Speckle-tracking Imaging in Patients with Primary Pulmonary Hypertension ESC Congress 2011.No 85975 Evaluation of Left Ventricular Diastolic Dysfunction by Doppler and 2D Speckle-tracking Imaging in Patients with Primary Pulmonary Hypertension Second Department of Internal

More information

Aortic Stenosis: Spectrum of Disease, Low Flow/Low Gradient and Variants

Aortic Stenosis: Spectrum of Disease, Low Flow/Low Gradient and Variants Aortic Stenosis: Spectrum of Disease, Low Flow/Low Gradient and Variants Martin G. Keane, MD, FASE Professor of Medicine Lewis Katz School of Medicine at Temple University Basic root structure Parasternal

More information

Basic Approach to the Echocardiographic Evaluation of Ventricular Diastolic Function

Basic Approach to the Echocardiographic Evaluation of Ventricular Diastolic Function Basic Approach to the Echocardiographic Evaluation of Ventricular Diastolic Function J A F E R A L I, M D U N I V E R S I T Y H O S P I T A L S C A S E M E D I C A L C E N T E R S T A F F C A R D I O T

More information

Tricuspid and Pulmonary Valve Disease

Tricuspid and Pulmonary Valve Disease Tricuspid and Pulmonary Valve Disease Lawrence Rudski MD FRCPC FACC FASE Professor of Medicine Director, Division of Cardiology Jewish General Hospital McGill University Right Sided Failure Edema Gut congestion

More information

SUDDEN CARDIAC DEATH IN ATHLETES

SUDDEN CARDIAC DEATH IN ATHLETES SUDDEN CARDIAC DEATH IN ATHLETES Alix Dufresne, MD, FACP, FACC, FESC Cardiology Division Chief, Interfaith Medical Center Director Cardiology Clinic, Kingsbrook Jewish Center PURPOSE AND OBJECTIVES PURPOSE

More information

22 nd Annual Conference of the Saudi Heart Association Riyadh, Saudi Arabia

22 nd Annual Conference of the Saudi Heart Association Riyadh, Saudi Arabia 22 nd Annual Conference of the Saudi Heart Association Riyadh, Saudi Arabia New Echocardiographic Modalities to Evaluate Ventricular Function in Congenital Heart Disease: Tissue Doppler & Strain Rate Imaging

More information

British Society of Echocardiography

British Society of Echocardiography British Society of Echocardiography Affiliated to the British Cardiac Society A Minimum Dataset for a Standard Adult Transthoracic Echocardiogram From the British Society of Echocardiography Education

More information

Mitral Valve Disease, When to Intervene

Mitral Valve Disease, When to Intervene Mitral Valve Disease, When to Intervene Swedish Heart and Vascular Institute Ming Zhang MD PhD Interventional Cardiology Structure Heart Disease Conflict of Interest None Current ACC/AHA guideline Stages

More information

Tricuspid and Pulmonary Valve Disease

Tricuspid and Pulmonary Valve Disease Tricuspid and Pulmonary Valve Disease Lawrence Rudski MD FRCPC FACC FASE Professor of Medicine Director, Division of Cardiology Jewish General Hospital McGill University Question 1 All of the following

More information

Paradoxical low flow-low gradient severe aortic stenosis: where are we?

Paradoxical low flow-low gradient severe aortic stenosis: where are we? Journées Européennes de la SFC Paris, 15 janvier 2016 Paradoxical low flow-low gradient severe aortic stenosis: where are we? Nicolas Mansencal Hôpital Ambroise Paré, Boulogne Centre de Réf ce pour les

More information

10/7/2013. Systolic Function How to Measure, How Accurate is Echo, Role of Contrast. Thanks to our Course Director: Neil J.

10/7/2013. Systolic Function How to Measure, How Accurate is Echo, Role of Contrast. Thanks to our Course Director: Neil J. Systolic Function How to Measure, How Accurate is Echo, Role of Contrast Neil J. Weissman, MD MedStar Health Research Institute & Professor of Medicine Georgetown University Washington, D.C. No Disclosures

More information

Evaluation of the Right Ventricle in Candidates for Right Ventricular Assist Device Implantation.

Evaluation of the Right Ventricle in Candidates for Right Ventricular Assist Device Implantation. Evaluation of the Right Ventricle in Candidates for Right Ventricular Assist Device Implantation. Evaluation of RVAD Function. Ioannis A Paraskevaidis Attikon University Hospital Historical Perspective

More information

What s New in Cardiac MRI

What s New in Cardiac MRI What s New in Cardiac MRI Katie M. Hawthorne, MD Director, Cardiac MRI Main Line Health Philadelphia Cardiovascular Summit November 18, 2017 Cardiac MRI: Disclosure 2 Disclosures No financial disclosures

More information

3/27/2014. Introduction.

3/27/2014. Introduction. Introduction. Myocardial perfusion & contractility becomes abnormal immediately after the onset of ischaemia, even before the development of the symptoms & ST segment changes. 1 Myocardial Wall Motion

More information

Evaluation of Left Ventricular Function and Hypertrophy Gerard P. Aurigemma MD

Evaluation of Left Ventricular Function and Hypertrophy Gerard P. Aurigemma MD Evaluation of Left Ventricular Function and Hypertrophy Gerard P. Aurigemma MD Board Review Course 2017 43 year old health assistant Severe resistant HTN LT BSA 2 Height 64 1 Here is the M mode echocardiogram

More information

Pre-participation Screening for the Prevention of sudden Cardiac Death in Young Athletes. Thomas W. Allen, DO, MPH

Pre-participation Screening for the Prevention of sudden Cardiac Death in Young Athletes. Thomas W. Allen, DO, MPH Pre-participation Screening for the Prevention of sudden Cardiac Death in Young Athletes Thomas W. Allen, DO, MPH Cardiovascular disorders are the leading cause of sudden death in young athletes accounting

More information

Normal ECG And ECHO Findings in Athletes

Normal ECG And ECHO Findings in Athletes Normal ECG And ECHO Findings in Athletes Dr.Yahya Kiwan Consultant Interventional Cardiologist Head Of Departement Of Cardiology Canadian Specialist Hospital Sinus Bradycardia The normal heartbeat is initiated

More information

Valvular Regurgitation: Can We Do Better Than Colour Doppler?

Valvular Regurgitation: Can We Do Better Than Colour Doppler? Valvular Regurgitation: Can We Do Better Than Colour Doppler? A/Prof David Prior St Vincent s Hospital Melbourne Sports Cardiology Valvular Regurgitation Valve regurgitation volume loads the ventricles

More information

Practical Echocardiography: ECHOES in the REAL WORLD Know When to Hold Em and When to Fold Em

Practical Echocardiography: ECHOES in the REAL WORLD Know When to Hold Em and When to Fold Em Practical Echocardiography: ECHOES in the REAL WORLD Know When to Hold Em and When to Fold Em Introduction The use of ultrasound in private veterinary practice is continuing to grow. The popularity of

More information

Νεότερα ςτην Υπερηχοκαρδιογραφία. Βαςίλειοσ Καμπερίδησ Clinical research fellow in Cardiology

Νεότερα ςτην Υπερηχοκαρδιογραφία. Βαςίλειοσ Καμπερίδησ Clinical research fellow in Cardiology Νεότερα ςτην Υπερηχοκαρδιογραφία Βαςίλειοσ Καμπερίδησ Clinical research fellow in Cardiology Disclosures ESC training grant EACVI research grant HCS training grant ELIKAR research grant Evolution of Echocardiography

More information

PRELIMINARY STUDIES OF LEFT VENTRICULAR WALL THICKNESS AND MASS OF NORMOTENSIVE AND HYPERTENSIVE SUBJECTS USING M-MODE ECHOCARDIOGRAPHY

PRELIMINARY STUDIES OF LEFT VENTRICULAR WALL THICKNESS AND MASS OF NORMOTENSIVE AND HYPERTENSIVE SUBJECTS USING M-MODE ECHOCARDIOGRAPHY Malaysian Journal of Medical Sciences, Vol. 9, No. 1, January 22 (28-33) ORIGINAL ARTICLE PRELIMINARY STUDIES OF LEFT VENTRICULAR WALL THICKNESS AND MASS OF NORMOTENSIVE AND HYPERTENSIVE SUBJECTS USING

More information

COMPLEX CONGENITAL HEART DISEASE: WHEN IS IT TOO LATE TO INTERVENE?

COMPLEX CONGENITAL HEART DISEASE: WHEN IS IT TOO LATE TO INTERVENE? COMPLEX CONGENITAL HEART DISEASE: WHEN IS IT TOO LATE TO INTERVENE? Aurora S. Gamponia, MD, FPPS, FPCC, FPSE OBJECTIVES Identify complex congenital heart disease at high risk or too late for intervention

More information

Μαρία Μπόνου Διευθύντρια ΕΣΥ, ΓΝΑ Λαϊκό

Μαρία Μπόνου Διευθύντρια ΕΣΥ, ΓΝΑ Λαϊκό Μαρία Μπόνου Διευθύντρια ΕΣΥ, ΓΝΑ Λαϊκό Diastolic HF DD: Diastolic Dysfunction DHF: Diastolic HF HFpEF: HF with preserved EF DD Pathophysiologic condition: impaired relaxation, LV compliance, LV filling

More information

Advanced Evaluation of Left Ventricular Function in Degenerative MR. Dr Julien Magne, PhD University of Liege, CHU Sart Tilman, Liege, Belgium

Advanced Evaluation of Left Ventricular Function in Degenerative MR. Dr Julien Magne, PhD University of Liege, CHU Sart Tilman, Liege, Belgium Advanced Evaluation of Left Ventricular Function in Degenerative MR Dr Julien Magne, PhD University of Liege, CHU Sart Tilman, Liege, Belgium Conflict of Interest Disclosure None Case Clinical data Previous

More information

Ref 1. Ref 2. Ref 3. Ref 4. See graph

Ref 1. Ref 2. Ref 3. Ref 4. See graph Ref 1 Ref 2 Ref 3 1. Ages 6-23 y/o 2. Significant LVM differences by gender 3. For males 95 th percentiles: a. LVM/BSA = 103 b. LVM/height = 100 4. For females 95 th percentiles: a. LVM/BSA = 84 b. LVM/height

More information

좌심실수축기능평가 Cardiac Function

좌심실수축기능평가 Cardiac Function Basic Echo Review Course 좌심실수축기능평가 Cardiac Function Seonghoon Choi Cardiology Hallym university LV systolic function Systolic function 좌심실수축기능 - 심근의수축으로심실에서혈액을대동맥으로박출하는기능 실제임상에서 LV function 의의미 1Diagnosis

More information

ECHO HAWAII. Role of Stress Echo in Valvular Heart Disease. Not only ischemia! Cardiomyopathy. Prosthetic Valve. Diastolic Dysfunction

ECHO HAWAII. Role of Stress Echo in Valvular Heart Disease. Not only ischemia! Cardiomyopathy. Prosthetic Valve. Diastolic Dysfunction Role of Stress Echo in Valvular Heart Disease ECHO HAWAII January 15 19, 2018 Kenya Kusunose, MD, PhD, FASE Tokushima University Hospital Japan Not only ischemia! Cardiomyopathy Prosthetic Valve Diastolic

More information